Insights / News

Controlant Announces Real-Time Supply Chain Visibility Solution For Low Temperature-Controlled Environments

New technology delivers on demand visibility for life sciences products requiring low temperature control and quality protection


Reykjavik and San Francisco (April 9, 2019) — Controlant, the leading independent provider of wireless Internet of Things (IoT) temperature monitoring and automated services for global digital cold chains, today announced the launch of its PR-T80 Digital Temperature Probe – an innovative real-time solution for pharmaceutical products requiring low temperature control and real-time visibility. The solution was unveiled at LogiPharma EU (Montreux, Switzerland).

The Controlant PR-T80 Digital Temperature Probe is the first real-time monitoring solution validated for pharmaceuticals and designed for dry ice applications, active pharmaceutical ingredients (API's), clinical trials, and additional pharmaceutical and life sciences products that require transport and storage in low temperature-controlled environments.

The new probe extends the capabilities of Controlant's Supply Chain Visibility solution, measuring low temperatures between -80C to 0C (-112F to +32F), and automatically sending data to a fully validated and compliant cloud software platform. Features include:

  • On demand access of data regarding a single shipment or for an entire supply chain
  • Temperature alerts sent by email and SMS
  • Shipment notifications visible in the Controlant software platform

Business intelligence provides pharmaceutical manufacturers and their supply chain partners with invaluable insights to proactively identify and mitigate supply chain risks, ensure quality and compliance, improve supply chain efficiency, and reduce costs.

Controlant at LogiPharma EU

Product Demonstration at booth #37. Attendees can see Controlant’s real-time monitoring solutions and services that track and report environmental conditions and product movement in real-time to connect global temperature-controlled supply chains and facilitate proactive intervention that substantially reduces both product and operational waste.

Case Study Presentation: “How to leverage developments in lane risk assessment on a global scale to significantly improve GDP compliance and logistics quality” on Tuesday, April 9th at 2:00pm. Gisli Herjolfsson, Controlant’s Co-founder and CEO, and Tommy Jennings, Associate Director Global Logistics, Allergan Pharmaceuticals, will co-present a case study during the Mastering Temperature Control and Logistics Track. The session will cover the challenges and considerations Allergan, a global pharmaceutical enterprise, faced when changing to a real-time temperature visibility solution for its global supply chain, and how technology and services have addressed their business, quality, and operational requirements.

Product Demonstration:  "Using Real-Time Temperature Data for Validation” on April 9th at 2:20 pm on the Demo Stage. Ada Palmadottir, MBA, MPharm, Business Development Director at Controlant, will lead a demo drawing on specific examples and use cases to explain the digital transformation in the supply chain and how pharmaceutical manufacturers can leverage Controlant’s real-time shipment data to make the most out of cost-saving improvements while meeting compliance and quality requirements.

“LogiPharma EU is the perfect venue for Controlant’s launch of its latest innovation. Top supply chain disruptors and decision makers from the world's largest pharmaceutical manufacturers will gather to share practical insights, best practices, and strategies related to end-to-end digital transformation,” said Mr. Herjolfsson. “Through our technology and customer successes, we are eager to help these enterprises transform their temperature-controlled supply chain strategies to adapt to the ever-changing demands while reducing costs, automating quality and compliance, driving efficiency, and implementing customer-centricity to enhance their patient-first initiatives.”